Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.

 

Important Public Notice: ANCC Magnet Recognition Program® - Site Visit through November 4, 2022. Click here to learn more.

MENU

Fox Chase Cancer Center Welcomes Dr. Nithya Cherukuru

August 2, 2022

Nithya Cherukuru, MD. Assistant Professor, Department of Medicine, Division of PsychiatryNithya Cherukuru, MD. Assistant Professor, Department of Medicine, Division of Psychiatry

PHILADELPHIA (August 2, 2022)—Fox Chase Cancer Center is pleased to announce the hiring of Nithya Cherukuru, MD, as an assistant professor in the Section of Psychiatry, where she will help patients cope with cancer throughout their treatment, from initial diagnosis to survivorship or end of life.

Prior to joining the Fox Chase faculty, Cherukuru worked at the University of Maryland School of Medicine as a consult and liaison psychiatry fellow. She has also worked at the Hamptons Veterans Affairs Medical Center as a staff psychiatrist and as a research assistant at the National Institute of Neurological Diseases and Stroke.

Cherukuru earned her undergraduate degree from Wake Forest University and attended the American University of the Caribbean, where she graduated with her medical degree in 2015. She went on to complete her psychiatry residency at Eastern Virginia Medical School, where she was elected chief resident.

Over the course of her career, Cherukuru has published multiple peer-reviewed articles. She has also received multiple honors and awards, including the Leadership in Hospital Governance Fellowship from Sentara Norfolk General and recognition as a professional role model from Eastern Virginia Medical School’s class of 2019. Additionally, she currently belongs to both the American Psychiatric Association and the Academy of Consult Liaison Psychiatry.

Cherukuru is also an experienced educator who has taught a range of subjects at both Eastern Virginia Medical School and the University of Maryland School of Medicine.

Cherukuru will begin her tenure at Fox Chase on August 8.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Connect with Fox Chase